Current Investigations

Hyland’s Teething Tablets

Homeopathic teething tablets and gels manufactured by Hyland’s have been recently linked to at least 10 children’s deaths and over 400 adverse events reported to the FDA. In October 2016, the safety regulator warned caregivers to stop using the tablets and gels, which have led to side-effects including fever, lethargy, vomiting, sleepiness, tremors, shortness of breath, irritability, agitation, and death. Read More


Essure is a permanent, non-surgical birth control solution for women. It prevents pregnancy by inserting of a pair of metal and fiber coils into the fallopian tubes that cause scar tissue to form, blocking sperm from reaching the egg. However the device has been linked to thousands of adverse event reports that prompted the FDA to issue a “black box warning” and other restrictions for Essure. It spawned lawsuits alleging that Essure’s manufacturer, Bayer HealthCare, concealed some adverse reactions from the FDA. In July 2018, Bayer announced that it would withdraw Essure from the market by the end of this year. If you have been affected, then you may be able to receive compensation for any incurred damages. Read More

Wright or MicroPort ProFemur Hip Lawsuit

ProFemur hip implants manufactured by Wright Medical or MicroPort Orthopedics have been pulled from the market due to their unexpected propensity to fracture, leading to acute injury and even death. Patients who received one of these hip implants may experience a sudden onset of severe pain, difficulty or inability to walk, or tingling sensations or numbness in the leg. Read More


Studies have shown that the use of talcum powder may increase a woman’s risk of developing ovarian cancer. Often termed the “silent killer,” ovarian cancer is considered one of the most deadly cancers in women. Cases have been filed nationwide against talcum powder manufacturers as well as talc mining companies who have are alleged to have failed to warn female consumers of the risks of genital dusting. Read more


Taxotere (docetaxel) is an injectable chemotherapy drug approved in the treatment of breast cancer as well as other forms of cancer, including prostate, stomach, head and neck cancers, and non-small cell lung cancer. Taxotere has recently spawned a number of lawsuits claiming that Taxotere’s manufacturer Sanofi-Aventis knew, or should have known, that the drug may cause permanent hair loss, and that Sanofi failed to adequately warn of those risks. Read More

Real Time Analytics